Cory Batenchuk

Title: Cory Batenchuk: Innovator in Virus-Derived Particle Technology

Introduction

Cory Batenchuk is a notable inventor based in Gatineau, Canada. He has made significant contributions to the field of biotechnology, particularly in the development of non-replicating virus-derived particles. His innovative work has the potential to impact various applications in medicine and research.

Latest Patents

Cory Batenchuk holds a patent for "Non-replicating virus-derived particles and uses thereof." This patent describes a non-replicating Rhabdovirus-derived particle that lacks the ability to spread between cells while exhibiting tropism against immortalized cells. The particle may also possess cytolytic tropism against these cells. Additionally, it has been noted that the particle can have innate and/or adaptive immune-stimulating properties, making it a valuable asset in therapeutic applications.

Career Highlights

Cory is currently associated with Celverum Inc., where he continues to advance his research and development efforts. His work at the company focuses on harnessing the unique properties of virus-derived particles for innovative solutions in the biomedical field.

Collaborations

Cory collaborates with talented individuals such as David Conrad and Fabrice Leboeuf. Their combined expertise contributes to the success of their projects and enhances the potential impact of their innovations.

Conclusion

Cory Batenchuk is a pioneering inventor whose work on non-replicating virus-derived particles showcases his commitment to advancing biotechnology. His contributions have the potential to lead to significant breakthroughs in medical applications.